The KLS Martin Group was founded in 2004 as an umbrella organization representing the following independent, medium-sized companies: KLS Martin LP, Gebrüder Martin, Karl Leibinger Medizintechnik, Rudolf Buck, KLS Martin GmbH and, Stuckenbrock Medizintechnik. The latest member of the Group is KLS Martin Manufacturing, LLC.
The initial company, Karl Leibinger Medizintechnik, was founded in 1896 as a surgical instrument manufacturer. The company expanded into global sales with the establishment of Gebrüder Martin in Tuttlingen, Germany in 1923. KLS Martin LP was founded in 1993 as the North American sales and marketing company. Currently, the KLS Martin Group employs over 1100 people worldwide with manufacturing on several continents.
The Group has wholly owned sales subsidiaries in Great Britain, France, Italy, the Netherlands, Japan, Australia, Brazil and Malaysia and maintains representative offices in Russia, China and Dubai. Additionally, the Group has distributers in more than 140 countries.
The KLS Martin Group is a world leader in the specialty markets of cranio-maxillofacial surgery, neurosurgery, cardiothoracic surgery, small bone orthopedics, electro surgical, surgical instruments and operating theater lights. The craniomaxillofacial market began in 1974 when the Karl Leibinger Medizintechnik factory developed the first 'miniplate' with Dr. Maxime Champy. This was the first production of miniaturized plate and screw osteosynthesis and sparked a new standard of care in facial trauma.
The KLS Martin Group became the market leader in Distraction Osteogenesis beginning with the widely published RED device, as well as the leader in Resorbable Osteosynthesis with the SonicWeld Rx® system. Additionally, the Group developed a unique product called the Sternal Talon for osteosynthesis of the sternum, fulfilling a need for rigid fixation in cardiothoracic surgery. The company continues to focus and invest in the future of osteosynthesis products, with special attention to the three-dimensional individual patient implant solutions (IPS).
The KLS Martin Group’s success throughout the world is due to innovative, high quality products, as well as excellent customer service and local sales consultants. The feedback and partnership with our customers and educational groups within cranio-maxillofacial surgery, neurosurgery, cardiothoracic surgery, small bone orthopedics are critical to developing our products that have advanced the field of surgical reconstruction.
In the future, the KLS Martin Group will continue to focus on its passion for developing innovative products that restore and transform patients throughout the world.
